All Resources
Dive deeper into cell mimic controls and learn more about how they work, what they’re being used to achieve, and where they’re making the biggest impact.
Feb 4, 2026
Press Releases
Slingshot Biosciences Announces Rapid Expansion into the United Kingdom and European Union Markets
Learn More2 min read
Oct 28, 2025
Press ReleasesPartnership
Slingshot Biosciences and Cellares combine TruCytes™ Biomarker Controls with the Cell Q™ platform to enhance quality and automation in Cell Therapy Manufacturing
Learn More3 min read
Oct 2, 2025
Press Releases
Slingshot Biosciences Launches TruCytes™ Potency CD20 & CD34 Stem Cell Gating Controls, Standardizing Critical Readouts While Slashing Variability, Time, and Cost
Learn More2 min read
May 28, 2025
Press ReleasesLeadership
Slingshot Biosciences Appoints Glenn Bilawsky as CEO to Lead Strategic Expansion across Clinical Trial and Diagnostic Markets
Learn More2 min read
May 6, 2025
Press Releases
Slingshot Biosciences Debuts TruCytes™ Potency—Cell Mimics for Scalable, Reproducible CAR-T Potency Assays
Learn More2 min read
How Potency Assay Strategy Can Accelerate Cell Therapy Development
Read Article9 min read
Education
Optimizing Controls for Flow Cytometry
Watch Now59 min
Bioscience
Reducing Time and Costs in Car-T Development with Precision-Engineered Cell Mimics
Read Article3 min read